| Metric | შპს აბულფარმ | შპს ფარმედ | შპს გლობალფარმი | შპს ბერლინ-ჰემი/ა. მენარინი დისთრიბუშენ ჯორჯია |
|---|---|---|---|---|
| Growth | ||||
| Revenue | ₾341.3m₾134.3m | ₾79.5m₾58.0m | ₾74.1m₾70.6m | ₾73.0m₾50.5m |
| Revenue growth | 154.2% | 37.1% | 4.9% | 44.5% |
| Profitability | ||||
| EBITDA | ₾179.9m₾48.4m | |||
| ₾12.1m₾13.0m |
| ₾2.6m₾1.9m |
| EBITDA margin | 52.7%36.0% | 31.1%26.3% | 16.4%18.4% | 3.6%3.8% |
| Net profit | ₾179.9m₾48.4m | ₾25.2m₾17.2m | ₾5.3m₾9.3m | ₾1.8m₾1.5m |
| Net margin | 52.7%36.0% | 31.7%29.6% | 7.2%13.1% | 2.5%3.0% |
| Balance sheet | ||||
| Total assets | ₾372.9m₾136.8m | ₾90.4m₾67.5m | ₾188.1m₾152.5m | ₾15.8m₾27.4m |
| Total equity | ₾237.4m₾49.7m | ₾77.5m₾52.3m | ₾37.5m₾37.3m | ₾10.0m₾10.4m |
| ROE | 75.8%97.4% | 32.5%32.8% | 14.1%24.9% | 18.3%14.4% |